BioGram ApS: Financial statements 2024
CVR: 40922598
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BioGram ApS (CVR 40922598) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 208,037 and a net result of DKK 170,237 compared with DKK 282,830 the year before. That is a decrease of 43.9% compared with the year before. Equity in the 2024 report amounted to DKK 603,430. The solvency ratio was 70.8%.
- Gross Profit
- DKK 208,037
- Profit/Loss
- DKK 170,237
- Equity
- DKK 603,430
- Total Assets
- DKK 851,755
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 208 t. | 170 t. | 603 t. | - |
| 2023 | - | 371 t. | 283 t. | 436 t. | - |
| 2022 | - | 52 t. | 103 t. | 256 t. | - |
| 2021 | - | 233 t. | 182 t. | 452 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BioGram ApS has published its annual report for 2023. Gross profit came to DKK 371,054, and the net result was DKK 282,830.
About BioGram ApS
BioGram ApS is a Danish company of the type Anpartsselskab based in Ølstykke, founded in 2019. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Per Gram. The company is owned by BioGram Holding ApS. In 2025, the company reported a gross profit of DKK 287,937 and a net result of DKK 222,179 compared with DKK 170,237 the year before. Equity in the 2025 report amounted to DKK 127,799.